Global Soft Tissue Allografts Market Growth, Trends, and Forecast Report 2019-2024 -

DUBLIN--()--The "Soft Tissue Allografts Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to's offering.

Rising demand for Soft Tissue Allografts in athletics & other sports is contributing largely to the market growth

Modern training regimens in athletics, field events and a number of other contact sports like the American football, require athletes to undergo intensive training sessions which are in practice more strenuous than the actual sport itself.

High-intensity training regimens are directly correlated with athletic performance improvement but excessive training also induces muscle and bone fatigue and often leads to injury. Consequently, injury prevalence among athletes has been increasing especially due to excessive training. The competitive nature of sports has spurred the demand among athletes for quick recovery and easily accessible modalities to treat musculoskeletal injuries.

As a result, the demand for soft tissue allografts has been increasing in athletics and other contact sports, which in turn is fuelling the growth of the global soft tissue allografts market. Other factors contributing to the growth of this market include the scientific advancements in soft tissue repair and replacement and an increasing geriatric population.

Scope of the Report

Soft tissue allografts are the substitute tissues, having application in the reconstruction of deficient ligaments, spinal surgeries, torn menisci, and osteochondral defects during knee surgeries.

Key Market Trends

Dentistry is Expected to Witness a Healthy Growth Over the Forecast Period

In countries such as India, Australia, the United States, etc., more attention is given to the aesthetics and this results in rising aesthetic procedures. Dentistry is the sector which is currently witnessing a large number of aesthetic procedures to improve dental appearance.

Along with that, dental disorders such as Periodontitis are also on the rise. For instance, the National Institute of Health has stated that periodontitis is affecting around 20-50% of the global population. Also, NIH has stated that around 44% of the people aged 65 and more are prone to have periodontal disease. Therefore, the need for proper treatment has increased.

The soft tissue allografts are used to stop the gum recession and to improve the appearance of the same. Along with the improved gum aesthetics, soft tissues are also beneficial in curing the periodontal disease which is augmenting the demand for the same across the globe. hence, it is indicated that the dentistry segment will show satisfactory growth over the forecast period.

North America Dominates the Market

Driven by the United States, North America is expected to dominate the market in the coming future. This is majorly due to factors such as increasing prevalence of diabetic foot ulcers, better healthcare awareness program for diabetes and an increase in a number of surgical procedures on anterior cruciate ligament (ACL). Furthermore, technological development in dental implants and increasing expenditure by major & small key players for the development of soft tissue allografts are also boosting the growth of the market studied in the North America region.

Competitive Landscape

The soft tissue allografts market is moderately competitive and many of the global players are into the market. For instance, Allergan Plc., B. Braun Melsungen AG, Conmed Corporation, etc. are providing these products across the globe. Also, new product launches from these players are augmenting the demand for these products.

Market Dynamics

Market Drivers

  • Increasing Geriatric Population
  • Increasing Demand for Soft Tissue Allografts in Athletics and Other Sports
  • Advancements in Soft Tissue Replacement

Market Restraints

  • High Cost of Treatment
  • Complicated Reimbursement Policies

Porter's Five Force Analysis

Companies Mentioned

  • Allergan Plc
  • B. Braun Melsungen AG
  • Conmed Corporation
  • Xtant Medical Holdings, Inc.
  • Alliqua BioMedical, Inc.
  • AlonSource Group
  • Becton Dickinson and Company
  • Arthrex, Inc.
  • Bone Bank Allografts
  • Osiris Therapeutics, Inc.
  • Integra LifeSciences Corporation
  • Stryker Corporation

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900